Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders.
Isacco CG, Ballini A, De Vito D, Nguyen KCD, Cantore S, Bottalico L, Quagliuolo L, Boccellino M, Di Domenico M, Santacroce L, Arrigoni R, Dipalma G, Inchingolo F.
Isacco CG, et al. Among authors: cantore s.
Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784. doi: 10.2174/1871530320666200729142504.
Endocr Metab Immune Disord Drug Targets. 2021.
PMID: 32727337
Review.